Dec 31, 2020 | News, Regulatory
According to Operation Warp Speed Chief, Moncef Slaoui, the AstraZeneca and Oxford University vaccine may not receive the U.S. Food and Drug Administration’s Emergency Use Approval (EUA) until April, despite the UK’s approval yesterday (12/30). Questions... 
Dec 4, 2020 | News, Regulatory
Countrywide, hospitals are preparing for the first 3.2 million shipments of Pfizer’s COVID-19 vaccine. The first round of shipments will be distributed to five government agencies before Moderna’s vaccine hits the market. State’s will have final say on... 
Dec 1, 2020 | News, Regulatory
After finding that the Johnson & Johnson vaccines triggered antibody cell formation to fight COVID-19, the European Medicines Agency (EMA) began to review the drug for emergency use authorization (EUA). Meanwhile, the company’s rivals Moderna and... 
Nov 16, 2020 | News, Regulatory
Based on long-term data from a late-stage trial including 30,000 participants, Moderna’s vaccine candidate has shown results of a 95% efficacy rate in fighting COVID-19. Moderna is planning to file for Emergency Use Authorization (EUA) in the coming weeks, ad by...
